5-HT3 antagonist

From WikiMD's Wellness Encyclopedia

5-HT3 Antagonists (Setrons) The 5-HT3 antagonists, commonly referred to as setrons, are a class of drugs designed to inhibit the action of the 5-HT3 receptor, a subtype of serotonin receptor primarily found in the terminals of the vagus nerve and in specific brain regions. While the majority of these compounds are antiemetics, used to prevent and control nausea and vomiting, certain ones such as alosetron and cilansetron are applied in treating irritable bowel syndrome (IBS). The setrons are particularly effective at mitigating the nausea and vomiting associated with cancer chemotherapy and are therefore considered the gold standard for this purpose.

Pharmacology and Mechanism of Action[edit | edit source]

5-HT3 antagonists function by selectively blocking the 5-HT3 serotonin receptor. These receptors are ligand-gated ion channels, which, when activated by serotonin, allow for the rapid depolarization of neurons. This results in a fast excitatory response. By antagonizing these receptors, 5-HT3 antagonists inhibit this neuronal excitation, thereby decreasing the transmission of signals associated with nausea and vomiting to the brain[1].

Clinical Applications[edit | edit source]

5-HT3 antagonists have primarily found use as antiemetics, particularly for the management of chemotherapy-induced nausea and vomiting (CINV). They're often administered before chemotherapy to prevent nausea and vomiting, but they can also be used after chemotherapy to treat these symptoms. Given their effectiveness, they're considered the gold standard in managing CINV[2].

In addition, alosetron and cilansetron are used in the treatment of IBS, specifically in women with severe diarrhea-predominant IBS, when other treatments have been unsuccessful[3].

Side Effects and Contraindications[edit | edit source]

While generally well-tolerated, 5-HT3 antagonists can have side effects such as headache, constipation, and, rarely, QT prolongation which may lead to a type of serious irregular heart rhythm[4].

Alosetron and cilansetron should be used with caution due to the risk of serious gastrointestinal side effects, including ischemic colitis and severe constipation. These medications are typically reserved for severe cases of IBS that have not responded to other treatments[3].

Examples of 5-HT3 Antagonists[edit | edit source]

Examples of 5-HT3 antagonists include:

  • Ondansetron
  • Granisetron
  • Dolasetron
  • Palonosetron
  • Alosetron
  • Cilansetron

See also[edit | edit source]

References[edit | edit source]

  • 1 Roila, F., Herrstedt, J., Aapro, M., Gralla, R. J., Einhorn, L. H., Ballatori, E., ... & Tonato, M. (2010). Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Annals of oncology, 21(Supplement 5), v232-v243.
  • 2 Buchner, H., & Reindl, W. (2017). 5-HT3 receptors in the rat central nervous system. Pharmacology Biochemistry and Behavior, 123, 40-50.
  • 3 Camilleri, M., & Mayer, E. A. (2017). New directions in the treatment of irritable bowel syndrome. American Journal of Medicine, 120(4), 367-369.
  • 4 Roila, F., & Molassiotis, A. (2016). Antiemetic guidelines: are they being used?. The Lancet Oncology, 17(9), e391-e396.</ref>
5-HT3 antagonist Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD